ออฟไลน์ด้วยแอป Player FM !
Pre- and Post- COVID-19 Exposure Prophylaxis: Ep4 - Hematologic Malignancies
Manage episode 322953402 series 2812899
In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination.
In this fourth episode of the series, we discuss:
- Response to COVID-19 vaccines in the general population
- Response to COVID-19 vaccines in immunocompromised people
- The impact of COVID-19 on patients with hematologic malignancies
- The potential role of pre- and post- COVID-19 exposure prophylaxis for people with hematologic malignancies
Our Guest:
Our guest on today’s episode is Dr. Carolyn Owen, who is an an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary.
This podcast episode was sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 ตอน
Manage episode 322953402 series 2812899
In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination.
In this fourth episode of the series, we discuss:
- Response to COVID-19 vaccines in the general population
- Response to COVID-19 vaccines in immunocompromised people
- The impact of COVID-19 on patients with hematologic malignancies
- The potential role of pre- and post- COVID-19 exposure prophylaxis for people with hematologic malignancies
Our Guest:
Our guest on today’s episode is Dr. Carolyn Owen, who is an an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary.
This podcast episode was sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 ตอน
ทุกตอน
×1 Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape 17:37
1 LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM 16:58
1 First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC 32:28
ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ